Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:98 |
|---|---|
| Enthalten in: |
American Journal of Hematology - 98(2023), 2, Seite 361-364 |
| Beteiligte Personen: |
Bayram, Ertugrul [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 Wiley Periodicals LLC. |
|---|
| Umfang: |
4 |
|---|
| doi: |
10.1002/ajh.26783 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY014927489 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY014927489 | ||
| 003 | DE-627 | ||
| 005 | 20231111122714.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/ajh.26783 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_AJH_2023_98_2.zip.xml |
| 035 | |a (DE-627)WLY014927489 | ||
| 035 | |a (WILEY)AJH26783 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Bayram, Ertugrul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy |
| 264 | 1 | |c 2023 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 Wiley Periodicals LLC. | ||
| 700 | 1 | |a Pehlivan, Umur Anil |4 aut | |
| 700 | 1 | |a Fajgenbaum, David C. |4 aut | |
| 700 | 1 | |a Paydas, Semra |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American Journal of Hematology |g 98(2023), 2, Seite 361-364 |w (DE-627)WLY001111442 |x 10968652 |7 nnns |
| 773 | 1 | 8 | |g volume:98 |g year:2023 |g number:2 |g pages:361-364 |g extent:4 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 98 |j 2023 |e 2 |h 361-364 |g 4 | ||